ExpreS2ion Biotech Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 18, 2022 at 02:30 am EDT
ExpreS2ion Biotech Holding AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 1.25 million compared to SEK 4.58 million a year ago. Revenue was SEK 1.58 million compared to SEK 4.79 million a year ago. Net loss was SEK 25.54 million compared to SEK 9.07 million a year ago. Basic loss per share from continuing operations was SEK 0.75 compared to SEK 0.32 a year ago.
For the six months, sales was SEK 3.28 million compared to SEK 6.29 million a year ago. Revenue was SEK 3.66 million compared to SEK 6.72 million a year ago. Net loss was SEK 39.37 million compared to SEK 20.22 million a year ago.